Citation Impact
Citing Papers
In vivo imaging of hydrogen peroxide production in a murine tumor model with a chemoselective bioluminescent reporter
2010 StandoutNobel
Parkinson-like syndrome induced by continuous MPTP infusion: Convergent roles of the ubiquitin-proteasome system and α-synuclein
2005 StandoutNobel
Strategy for Dual-Analyte Luciferin Imaging: In Vivo Bioluminescence Detection of Hydrogen Peroxide and Caspase Activity in a Murine Model of Acute Inflammation
2013 StandoutNobel
Mediation of Poly(ADP-Ribose) Polymerase-1-Dependent Cell Death by Apoptosis-Inducing Factor
2002 StandoutScience
Chaperone Suppression of α-Synuclein Toxicity in a Drosophila Model for Parkinson's Disease
2002 StandoutScience
Suppression of Reactive Oxygen Species and Neurodegeneration by the PGC-1 Transcriptional Coactivators
2006 Standout
Loss of PINK1 Function Promotes Mitophagy through Effects on Oxidative Stress and Mitochondrial Fission
2009
Large scale mitochondrial sequencing in Mexican Americans suggests a reappraisal of Native American origins
2011
Divorcing the Late Upper Palaeolithic demographic histories of mtDNA haplogroups M1 and U6 in Africa
2012
Mitochondrial lineage M1 traces an early human backflow to Africa
2007
Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein
1992 StandoutNatureNobel
AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity
2009 StandoutNature
Refinement of Structural Leads for Centrally Acting Oxime Reactivators of Phosphylated Cholinesterases
2012 StandoutNobel
Mitochondrial DNA haplogroup H structure in North Africa
2009
The DNA-damage response in human biology and disease
2009 StandoutNature
Allosteric Modulation of Muscarinic Acetylcholine Receptors
2007
Mitochondrial DNA Mutations in Disease, Aging, and Neurodegeneration
2008
Pharmacology of nootropics and metabolically active compounds in relation to their use in dementia
1990
Mitochondria, free radicals, and neurodegeneration
1996
Mitochondrial Dysfunction in Neurodegeneration
1997
Counting the Founders: The Matrilineal Genetic Ancestry of the Jewish Diaspora
2008
α-Synuclein Promotes Mitochondrial Deficit and Oxidative Stress
2000
p53 inhibitors preserve dopamine neurons and motor function in experimental parkinsonism
2002
Mechanisms and Functional Implications of Adult Neurogenesis
2008 Standout
X11 Interaction with β-Amyloid Precursor Protein Modulates Its Cellular Stabilization and Reduces Amyloid β-Protein Secretion
1998
The parkinsonian neurotoxin MPP+ opens the mitochondrial permeability transition pore and releases cytochrome c in isolated mitochondria via an oxidative mechanism
1999
Mitochondria are a direct site of Aβ accumulation in Alzheimer's disease neurons: implications for free radical generation and oxidative damage in disease progression
2006
Formation and Removal of α-Synuclein Aggregates in Cells Exposed to Mitochondrial Inhibitors
2002
The Importance of Dendritic Mitochondria in the Morphogenesis and Plasticity of Spines and Synapses
2004
Mitochondrial dysfunction, apoptotic cell death, and Alzheimer’s disease
2003
MPTP Activates c‐Jun NH2‐Terminal Kinase (JNK) and Its Upstream Regulatory Kinase MKK4 in Nigrostriatal Neurons In Vivo
2000
Mitochondria dysfunction of Alzheimer's disease cybrids enhances Aβ toxicity
2004
Ethiopian Mitochondrial DNA Heritage: Tracking Gene Flow Across and Around the Gate of Tears
2004
Nonalcoholic Fatty Liver Disease
2002 Standout
Updating the East Asian mtDNA phylogeny: a prerequisite for the identification of pathogenic mutations
2006
Mitochondrial DNA haplogroup cluster UKJT reduces the risk of PD
2005
Characterization of the human heart mitochondrial proteome
2003
High Resolution Analysis and Phylogenetic Network Construction Using Complete mtDNA Sequences in Sardinian Genetic Isolates
2006
Targeting oxidative stress in disease: promise and limitations of antioxidant therapy
2021 Standout
Mitochondrial abnormalities in non-alcoholic steatohepatitis
1999
Psychedelics
2016 Standout
Amyloid beta, mitochondrial dysfunction and synaptic damage: implications for cognitive decline in aging and Alzheimer's disease
2008
A mitochondrial genome sequence of a hominin from Sima de los Huesos
2013 StandoutNatureNobel
Oxidative Stress in the Progression of Alzheimer Disease in the Frontal Cortex
2010
Genetic aspects of Parkinson's disease
1998
The Emerging Limbs and Twigs of the East Asian mtDNA Tree
2002
Complete Mitochondrial Genomes Reveal Neolithic Expansion into Europe
2012 StandoutNobel
Somatic mitochondrial DNA mutations in cortex and substantia nigra in aging and Parkinson’s disease
2003
Mitochondria: In Sickness and in Health
2012 Standout
Structure of the human M2 muscarinic acetylcholine receptor bound to an antagonist
2012 StandoutNatureNobel
Mitochondria, Oxidants, and Aging
2005 Standout
Blinded by the Light: The Growing Complexity of p53
2009 Standout
Mutational analysis of muscarinic acetylcholine receptors: Structural basis of ligand/receptor/g protein interactions
1993
Mitochondrial control of cell death
2000 Standout
A new computer program for detailed off-line analysis of swimming navigation in the Morris water maze
1992
Oxidative stress and Alzheimer disease
2000 Standout
No Evidence for an mtDNA Role in Sperm Motility: Data from Complete Sequencing of Asthenozoospermic Males
2007
Mitochondrial dysfunction in neurodegenerative disorders
1998
More hippocampal neurons in adult mice living in an enriched environment
1997 StandoutNature
Enhanced substantia nigra mitochondrial pathology in human α-synuclein transgenic mice after treatment with MPTP111-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
2003
High aggregate burden of somatic mtDNA point mutations in aging and Alzheimer's disease brain
2002
α-Synuclein Cooperates with CSPα in Preventing Neurodegeneration
2005 StandoutNobel
Effects of Xanomeline, a Selective Muscarinic Receptor Agonist, on Cognitive Function and Behavioral Symptoms in Alzheimer Disease
1997
Five-Year Follow-up of Bilateral Stimulation of the Subthalamic Nucleus in Advanced Parkinson's Disease
2003 Standout
On the Discovery and Development of Pimavanserin: A Novel Drug Candidate for Parkinson’s Psychosis
2014
Autophagy in Human Health and Disease
2013 Standout
α-Synuclein: Normal Function and Role in Neurodegenerative Diseases
2004
Dopamine Oxidation Alters Mitochondrial Respiration and Induces Permeability Transition in Brain Mitochondria
1999
The Charcot–Marie–Tooth type 2A gene product, Mfn2, up-regulates fuel oxidation through expression of OXPHOS system
2005
Maternal inheritance in Parkinson's disease
1997
Genetic variation in South Indian castes: evidence from Y-chromosome, mitochondrial, and autosomal polymorphisms
2008
Alzheimer's Disease
2010 Standout
Parkinson's Disease
1998 Standout
Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases
2006 StandoutNature
Low Mutational Burden of Individual Acquired Mitochondrial DNA Mutations in Brain
2001
Mitochondrial dysfunction in sporadic and genetic Alzheimer's disease
2006
Cyclosporin A Increases Resting Mitochondrial Membrane Potential in SY5Y Cells and Reverses the Depressed Mitochondrial Membrane Potential of Alzheimer's Disease Cybrids
1998
Muscarinic acetylcholine receptors: mutant mice provide new insights for drug development
2007
An Essential Role of the Mitochondrial Electron Transport Chain in Cell Proliferation Is to Enable Aspartate Synthesis
2015
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
2015 Standout
Mitochondrial DNA Phylogeny in Eastern and Western Slavs
2008
Structure and dynamics of the M3 muscarinic acetylcholine receptor
2012 StandoutNatureNobel
Mitochondrial DNA damage and repair in neurodegenerative disorders
2008
Reconstructing Indian population history
2009 StandoutNature
Does the mitochondrial genome play a role in the etiology of Alzheimer’s disease?
2006
Pathways towards and away from Alzheimer's disease
2004 StandoutNature
Parkinson's Disease
2003 Standout
Mitochondrial DNA Haplogroups and Age-Related Maculopathy
2007
Mutagenic Mapping Suggests a Novel Binding Mode for Selective Agonists of M1 Muscarinic Acetylcholine Receptors
2008
Sequence Analysis of the Entire Mitochondrial Genome in Parkinson's Disease
2002
Proapoptotic BAX and BAK: A Requisite Gateway to Mitochondrial Dysfunction and Death
2001 StandoutScience
Rolipram, a type IV-specific phosphodiesterase inhibitor, facilitates the establishment of long-lasting long-term potentiation and improves memory
1998 StandoutNobel
A Neural Substrate of Prediction and Reward
1997 StandoutScience
Biologically active quinoline and quinazoline alkaloids part I
2017
DNA analysis of an early modern human from Tianyuan Cave, China
2013 StandoutNobel
Familial multisystem degeneration with parkinsonism associated with the 11778 mitochondrial DNA mutation
1999
Ancient Ethiopian genome reveals extensive Eurasian admixture in Eastern Africa
2015 StandoutScience
Complex Trait Analysis of the Hippocampus: Mapping and Biometric Analysis of Two Novel Gene Loci with Specific Effects on Hippocampal Structure in Mice
2001
Transcriptional neoteny in the human brain
2009 StandoutNobel
Transgenic mice expressing human Bcl-2 in their neurons are resistant to 6-hydroxydopamine and 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine neurotoxicity
1998
Mitochondrial Abnormalities in Alzheimer's Disease
2001
Homologation of the Fischer Indolization: A Quinoline Synthesis via Homo‐Diaza‐Cope Rearrangement
2020 StandoutNobel
GSK-3 is essential in the pathogenesis of Alzheimer's disease
2006
Pleistocene North African genomes link Near Eastern and sub-Saharan African human populations
2018 StandoutScienceNobel
Spermidine in health and disease
2018 StandoutScience
Gold Nanoparticles in Chemical and Biological Sensing
2012 Standout
Copper induces cell death by targeting lipoylated TCA cycle proteins
2022 StandoutScience
Colorimetric Assay of Glutathione Based on the Spontaneous Disassembly of Aggregated Gold Nanocomposites Conjugated with Water-Soluble Polymer
2010
Cybrids in Alzheimer's disease: A cellular model of the disease?
1998
Regulation of adult neurogenesis by excitatory input and NMDA receptor activation in the dentate gyrus
1995
Cybrids in Alzheimer's disease: A cellular model of the disease?
1998
Impaired Degradation of Mutant α-Synuclein by Chaperone-Mediated Autophagy
2004 StandoutScience
Amidine−Oximes: Reactivators for Organophosphate Exposure
2011
The role of dopamine in locomotor activity and learning
1983
More reliable estimates of divergence times inPanusing complete mtDNA sequences and accounting for population structure
2010
International Union of Pharmacology. XVII. Classification of Muscarinic Acetylcholine Receptors
1998
Capacitative Calcium Entry Deficits and Elevated Luminal Calcium Content in Mutant Presenilin-1 Knockin Mice
2000
Mutations in the DJ-1 Gene Associated with Autosomal Recessive Early-Onset Parkinsonism
2003 StandoutScience
A role for Mints in transmitter release: Mint 1 knockout mice exhibit impaired GABAergic synaptic transmission
2003 StandoutNobel
Works of Robert E. Davis being referenced
Altered Calcium Homeostasis in Cells Transformed by Mitochondria from Individuals with Parkinson's Disease
1997
Two-dimensional electrophoresis and mass spectrometric identification of mitochondrial proteins from an SH-SY5Y neuroblastoma cell line
2001
The role of M1 muscarinic receptor agonism of N-desmethylclozapine in the unique clinical effects of clozapine
2004
Creation and Characterization of Mitochondrial DNA‐Depleted Cell Lines with “Neuronal‐Like” Properties
1996
Reduced-Median-Network Analysis of Complete Mitochondrial DNA Coding-Region Sequences for the Major African, Asian, and European Haplogroups
2002
Abnormal Mitochondrial Morphology in Sporadic Parkinson's and Alzheimer's Disease Cybrid Cell Lines
2000
PET analysis of the 5-HT2A receptor inverse agonist ACP-103 in human brain
2007
Rapid activation of heat shock factor-1 DNA binding by H2O2 and modulation by glutathione in human neuroblastoma and Alzheimer's disease cybrid cells
1999
Cognition activators
1988
Structural Requirements of Transmembrane Domain 3 for Activation by the M1 Muscarinic Receptor Agonists AC-42, AC-260584, Clozapine, and N-Desmethylclozapine: Evidence for Three Distinct Modes of Receptor Activation
2006
Origin and functional consequences of the complex I defect in Parkinson's disease
1996
Water-maze learning and effects of cholinergic drugs in mouse strains with high and low hippocampal pyramidal cell counts
1988
Pimavanserin tartrate, a 5-HT2A receptor inverse agonist, increases slow wave sleep as measured by polysomnography in healthy adult volunteers
2011
The Effects of Food on the Pharmacokinetics of a Formulated ACP‐103 Tablet in Healthy Volunteers
2007
Pharmacokinetics, Tolerability, and Safety of ACP‐103 Following Single or Multiple Oral Dose Administration in Healthy Volunteers
2007
MPP+ Inhibits Proliferation of PC12 Cells by a p21WAF1/Cip1-Dependent Pathway and Induces Cell Death in Cells Lacking p21WAF1/Cip1
1999
Pharmacological Characterization of AC-90179 [2-(4-Methoxyphenyl)-N-(4-methyl-benzyl)-N-(1-methyl-piperidin-4-yl)-acetamide Hydrochloride]: A Selective Serotonin 2A Receptor Inverse Agonist
2004
Interleukin‐1β dissociates β‐amyloid precursor protein and β‐amyloid peptide secretion
1994
Chapter 54: Subtype selective muscarinic agonists: potential therapeutic agents for Alzheimer's disease
1993
Characterization of muscarinic agonists in recombinant cell lines
1993
Psychosis of Parkinson's disease: serotonin 2A receptor inverse agonists as potential therapeutics.
2003
Cybrids in Alzheimer's disease: A cellular model of the disease?
1997
In vitro and in vivo evaluation of the subtype-selective muscarinic agonist PD 151832
1995
Acetylcholinesterase inhibition by fused dihydroquinazoline compounds
1996
Behavioral effects of unilateral dopamine injection into dorsal or ventral striatum
1981
Calcium Homeostasis and Reactive Oxygen Species Production in Cells Transformed by Mitochondria from Individuals with Sporadic Alzheimer’s Disease
1997